Company intelligence / Profile preview

Apothyx

Toronto , Ontario , Canada apothyx.co ↗

Ownership: Private
Employees: ~8000
Development stage: Commercial

Overview

Apotex is Canada's largest producer of generic drugs with over CA$3.9 billion in annual sales and more than 300 products marketed in over 115 countries. The company manufactures and distributes generics and biosimilars across major therapeutic areas including oncology, cardiology/metabolic diseases (diabetes/cholesterol), ophthalmology (glaucoma), infectious diseases and more[4][5][6].

Therapeutic areas: Psychiatry
Modalities: Small moleculesBiosimilarsActive Pharmaceutical Ingredients (APIs)
Industry: Biotech

Partnerships

Formosa Pharmaceuticals (exclusive Canadian rights to APP13007)[5]

Beyond the preview

Go deeper on Apothyx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apothyx.

Explore the full profile